Medtech giant separates

Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...

Early stage research and low turnaround dominates

Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...

With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

Danish discovery could help cardiac patients

The Danish researchers have developed a component that could make live easier forpatients with heart failure.

Time to save for survival

The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.

Swedish nanotech crosses the Atlantic

Genovis signs distribution agreement Finnzymes in US.

Apoteket gets new vice CEO

The Swedish government company Apoteket has recently appointed a vice CEO.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Biovitrum sells UK part

Biovitrum will soon spin-out a British subsidary

A smart company takes care of its best

Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.

Novo och Astra ligger bra till i internationell kraftmätning

Patentutgångar kommer under de närmaste åren att drabba flera stora läkemedelsbolag, men Astrazeneca och Novo Nordisk hör till de som skymtar ljusglimtar enligt en analys.

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

Finnish-Dutch engineering cooperation continues

The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.

New influenza vaccine to EU

The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.

9 steps to perfect partnering

Rigorous planning and a focus on your business plan is essential for successful partnering, accoring to Camilla Huse Bondeson at Conlega. Follow her 9 steps to ...

IRW Consulting is seeking Clinical Research Managers

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Anything is measurable

At the seminar "Du är vad jag mäter - hjärnans kemi i ett provrör", Jonas Bergquist, professor of analytical chemistry and neurochemistry, will dig deep into th...

Varumärke en het fråga för läkemedelsbolagen

- Det får inte vara förväxlingsbart med tidigare varumärken och heller inte väcka anstöt eller bryta mot lagen, säger Magnus Ahlgren, juristchef på PRV:s design...

Welcome to wonderful Copenhagen

Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...

Cancer cells cheat suicide call

Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of...

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.